To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Neonatal encephalopathy (NE) is a clinical disorder of brain function that arises from various conditions impacting the central nervous system around the time of birth. Key symptoms include altered consciousness, respiratory depression, cranial nerve dysfunction, tone abnormalities, and seizures. The incidence of NE is estimated at 3 per 1,000 live births, with hypoxic–ischemic encephalopathy (HIE) accounting for approximately 1–1.5 per 1,000 live term births. Recent debates have centered around the definition and diagnosis of HIE, particularly concerning cerebral blood flow and oxygen delivery at birth. Identifying infants at high risk for evolving HIE is crucial, as therapeutic hypothermia, the only known treatment that can improve neurological outcomes, needs to be administered within 6 hours of birth. This chapter focuses on HIE as a distinct cause of NE, detailing its diagnosis and management, and discusses other conditions that may present with encephalopathy at different times post-delivery.
Hypoxic–ischemic encephalopathy (HIE) is a common cause of neonatal encephalopathy and requires careful and prompt diagnosis in order to initiate therapeutic hypothermia, a time-sensitive neuroprotective treatment. The clinical presentation is key in distinguishing HIE from other causes of neonatal encephalopathy and includes assessment of Apgar scores, physiologic markers of acute hypoxia such as the initial blood gas, the presence of an acute hypoxic–ischemic event, and exam findings consistent with a moderate or severe degree of encephalopathy. Specific eligibility criteria exist for each of these factors and are standardized across centers. Neurodiagnostic tools important for the evaluation and management of HIE include the electroencephalogram (EEG) and magnetic resonance imaging (MRI). EEG can help assess the degree of encephalopathy, provide early prognostic information, and detect subclinical seizures. The MRI is the gold standard imaging test to evaluate the location and degree of HIE injury and provide the most accurate information about long-term outcome.
Nearly all infants are exposed to repeated but usually short periods of compromised gas exchange before and during labor, and yet only a remarkably small proportion of newborns develop hypoxic–ischemic encephalopathy (HIE). Indeed, even severe metabolic acidosis at birth is associated with HIE in less than half of cases. Similarly, experimental studies typically report that cerebral injury occurs only in a very narrow temporal window between survival with complete recovery and death. In part, this reflects the remarkable efficacy of fetal adaptations that maintain perfusion to the essential organs. However, it also reflects a fine balance between injurious events triggered by hypoxia–ischemia and countervailing endogenous protective processes that help limit neural injury. These processes may be modified, raising the possibility of treating acute encephalopathy.
Inborn errors of metabolism and abnormalities in many single genes related to neuronal function can have clinical, biochemical, and neuroradiologic features similar to those of neonatal encephalopathy caused by environmental factors, such as in-utero hypoxia, ischemia, inflammation, or infection. Both genetic disorders and neonatal encephalopathy secondary to environmental factors, such as hypoxic–ischemic encephalopathy (HIE) or fetal inflammatory response syndrome, may be associated with severe neurologic distress, metabolic acidosis, brain imaging abnormalities, and multiorgan system involvement. Although newborn screening using tandem mass spectrometry (MS/MS) can detect numerous metabolic disorders, many inborn errors of metabolism that present with HIE-like features will be missed, so specialized biochemical tests or next-generation gene sequencing studies are required in order to establish a diagnosis. Prompt diagnosis of an underlying genetic disorder not only may prevent mortality or significant morbidity but also may allow the clinician to provide the family with comprehensive genetic counseling.
Neonatal seizures are commonly encountered in the neonatal intensive care unit and are often a sign of underlying acute brain injury. Seizures in this age group have high rates of subclinical or electrographic only features, and thus continuous EEG monitoring is necessary for accurate and prompt diagnosis. Treatment of seizures is considered emergent, as ongoing seizures can amplify brain injury and worsen neurodevelopmental outcomes. Specific antiseizure medications used in this age group come from expert experience and consensus, but further clinical trials are needed to determine the safety and efficacy of newer medications that may be less toxic to the developing brain.
Hypoxemia poses a significant threat to fetal survival and development, often leading to neurodevelopmental disabilities including cerebral palsy or death. However, predicting and intervening in these cases remains challenging, despite advancements like therapeutic hypothermia. Abnormal fetal heart rate patterns provide only weak predictions of risk of acidemia and associated outcomes. Although severe metabolic acidemia correlates more strongly with neonatal outcomes, many infants with acute hypoxic–ischemic encephalopathy present with milder abnormalities, highlighting the complexity of hypoxic events. Modern studies indicate that only a fraction of cases of cerebral palsy are directly linked to intrapartum hypoxia-ischemia, and that a significant proportion of severe cases develop antenatally. This chapter will explore the mechanisms through which fetal adaptation to hypoxemia operates, circumstances that lead to failure of adaptation and subsequent brain injury, and the factors influencing the fetus’s ability to mitigate damage from hypoxia–ischemia.
Hypoxic–ischemic encephalopathy (HIE) is a form of brain damage in infants caused by reduced blood and oxygen supply to the brain, occurring in about 1–3 infants per 1,000 live term births in America and Western Europe. Damage can be mild, moderate, or severe and can cause death or long-term neurological, cognitive, and behavioral disabilities. Worldwide nearly 1 million infants die each year from HIE after perinatal asphyxia. Hypothermia (HT) is the only approved treatment for neonatal HIE in western countries. However, about one third of the infants who receive whole-body or head cooling still have moderate-to-severe impairments in executive, visuospatial, and motor functions, language, and emotional maturity years later. A better understanding of the process of neonatal brain degeneration and the mechanisms of HT neuroprotection and persistence of injury will help to develop additional therapeutics. We explore four key mechanistic aspects of neonatal brain injury to potentially catalyze progress: connectivity or connectomics; proteinopathy; cell death; and the proteasome. In this chapter we discuss these four aspects of neonatal brain injury and their possible interrelations.
Over the past 30 years, advancements in our understanding of brain development have transformed neonatal care. The establishment of NNCC as a distinct specialty, accredited in 2022, underscores the necessity for a multidisciplinary approach involving neonatology, neurology, neurophysiology, nursing, and neuroradiology. The first dedicated program was initiated in 2008, paving the way for improved brain monitoring techniques, such as amplitude-integrated electroencephalography, continuous EEG, and near-infrared spectroscopy, which facilitate timely identification and management of neurological conditions. Effective NNCC programs require substantial investment in equipment, staff training, and the development of tailored protocols to address the unique needs of NICU patients. Evidence suggests that focused brain care is crucial for all neonates, particularly those with conditions like hypoxic–ischemic encephalopathy and seizures. Integration of specialized care has demonstrated benefits, including reduced exposure to antiseizure medications and improved diagnostic accuracy. We highlight the essential components of NNCC programs and their role in optimizing neurodevelopmental outcomes for vulnerable infants.
Neonatal encephalopathy (NE) encompasses a range of disorders presenting with altered brain function in neonates, often leading to long-term neurodevelopmental deficits. Characterized by symptoms such as altered consciousness, poor tone, and seizures, NE occurs in 1–6 per 1,000 live term births and is a major cause of neurodevelopmental disabilities. Although many cases relate to hypoxic–ischemic injury, other causes include metabolic disorders, infections, and congenital anomalies. The introduction of therapeutic hypothermia (TH) has improved outcomes for infants with hypoxic–ischemic encephalopathy (HIE), significantly reducing the incidence of severe neurodevelopmental disabilities. However, variations in practices and results persist, and adjunct therapies such as erythropoietin have not shown effective benefits. The chapter discusses the spectrum of neurocognitive impairments following HIE, predictors of outcomes based on brain injury patterns, and highlights ongoing research to understand the long-term impact of these interventions on affected individuals.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.